CLSD Stock Posts

Clearside Biomedical will report earnings after the market closes. View Calendar The market is expecting a ±7.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.6%. View Expected Move

Clearside Biomedical will report earnings after the market closes. View Calendar The market is expecting a ±10.8% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±2.8%. View Expected Move (Conf Call: Mar 27 4:30 PM)

Clearside Biomedical will report earnings after the market closes. View Calendar The market is expecting a ±6.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±2.7%. View Expected Move (Conf Call: Nov 12 4:30 PM)

Clearside Biomedical trades 4,463 contracts. The company has the following event: Clinical Trial Update Investor Call on Oct 9, 2024. News: Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes